Bon usage des médicaments inhalés intégré au plan pharmaceutique personnalisé en service de pneumologie

Abstract

IntroductionThe updated clinical pharmacy model places the pharmacist at the heart of the healthcare service. A targeted action on the proper use of inhalers in the Personalized Pharmaceutical Plan (PPP) is integrated into the activity of the clinical pharmacist in pneumology. Materials and methodsThe pharmacist carries out medication reconciliations at hospital admission including a proper use of inhaler evaluation, elaborates Personalized Pharmaceutical Plans which can contain proper use of inhalers action and realizes pharmaceutical analysis in the medical unit. To assess the proper use of inhalers, the pharmacist makes a score based on a checklist for each inhaler. Patients are assessed during admission and 30 days after hospitalization by telemedicine tools. The study aims to assess the clinical pharmacist's impact on the proper use of inhalers evolution, on medication errors solved during medication reconciliation and pharmaceutical analysis. ResultsBetween November 2021 and April 2022, medication reconciliations were established for 152 patients. Proper use score improvement is 12.4% (P<0.01), from 81.7% at admission to 94.1% 30 days after discharge on 44 patients and 53 assessments. Clinical pharmacist resolved 316 medical errors during medication reconciliation, 290 during hospitalization and 89 at patient discharge. DiscussionA lack of control of inhaled medications is often identified in studies. This work demonstrates the significant improvement brought about by clinical pharmacy actions. The multiplicity of inhaler types implies many different types of error, but a significant proportion of errors remain solely patient-related. The various clinical pharmacy activities allow for an overall improvement in the quality of drug management. ConclusionIn our study, the clinical pharmacist, present in pulmonology on a daily basis, increases the proper use of inhalers and reduces medication errors with medication reconciliation and pharmaceutical analysis in the health unit.